[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.19.31. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 9, 2002

Cost-effectiveness of Homocysteine-Lowering Therapy to Prevent Coronary Heart Disease

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior Editor

 

Not Available

JAMA. 2002;287(2):191. doi:10.1001/jama.287.2.191-JLT0109-3-3

To the Editor: Dr Tice and colleagues1 concluded that grain fortification with folic acid and cyanocobalmin would be cost-effective, and even cost-saving, in reducing the risk of primary and secondary heart disease in the US population. However, 2 statements by the authors raise serious issues regarding the appropriate policy application of their findings.

First Page Preview View Large
First page PDF preview
First page PDF preview
×